Skip to main content
OpenTrials
Completed

NCT Number: NCT04930666

BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease

This study aims to:

1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptability of intervention procedures; and 3. To explore intervention effects on ALD outcomes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Disease, Chronic Obstructive Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Interstitial Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Weill Cornell Medical Center

New York, 10065, United States

About this study

This study addresses the important problem of adults with symptomatic advanced lung disease (ALD) who are at high risk for poor outcomes. Palliative care (PCare) improves the quality of life of individuals and their caregivers through the prevention and relief of suffering by identifying, assessing and treating the physical, psychosocial and spiritual problems associated with life-threatening illness. However, pulmonary clinicians rarely refer adults with ALD to PCare because of time demands, a lack of confidence in PCare and the perceived threat PCare poses to the relationship they have established with the ALD adult. Therefore, we are developing BREATHE-ALD (BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease [ALD]), a novel shared decision-making (SDM) intervention to improve outcomes for adults with ALD.

The study includes two phases: (1) a development phase to develop BREATHE-ALD using interviews with 10 ALD adults and their caregivers with expert review to adapt BREATHE, and (2) a pilot validation phase conducting a pilot trial in which 10 adults with ALD receive BREATHE-ALD. We will follow adults with ALD for 3 months post-intervention to assess the impact of BREATHE-ALD on self-management and patient outcomes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Pre-trial

Inclusion criteria

  • Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
  • Caregiver participants who care for adults with symptomatic ALD followed at Weill Cornell Medicine.

Exclusion criteria

  • Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
  • Caregivers that have serious mental health conditions that preclude completion of study procedures or confound analyses.

Trial

Inclusion criteria

  • Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
  • Nurse practitioner must manage a panel of adult ALD patients.

Exclusion criteria

  • Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
  • Patients anticipated to have less than 3-month survival.

Treatment and study plan

BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease

Other

BREATHE-ALD utilizes the patient's nurse practitioner (NP) to deliver a brief intervention using motivational interviewing and shared decision making, in a one-time 9-minute intervention. The NP will follow a 4-step script tailored to specific ALD self-management discussed during the most recent visit with the patient's pulmonologist. Step 1: Raise the subject (1½ minute). Step 2: Provide feedback (1½ minutes). Step 3: Enhance engagement (3 minutes). Step 4: Shared decision-making (3 minutes).

Other names: BREATHE-ALD

Primary outcomes

  1. Number of qualitative interviews completed in the development phase

    Time frame: Up to 6 months

    Qualitative interviews will be conducted with adults with advanced lung disease and their caregivers to understand their experiences managing ALD using semi-structured in-depth individual interviews. The information collected will aid the design of BREATHE-ALD and the implementation of the pilot phase of this study.

  2. Ratio of participants who completed the intervention to the number of participants consented

    Time frame: Up to 3 months post-intervention

    To determine the level of retention, the ratio of participants who completed the intervention to the number of participants consented will be measured.

  3. Mean mMRC (Modified Medical Research Council) Dyspnea Scale

    Time frame: Up to 3 months post-intervention

    The mMRC (Modified Medical Research Council) Dyspnea Scale measures the effect of breathlessness when performing daily activities. The mMRC breathlessness scale comprises five statements that describe almost the entire range of respiratory disability from none (Grade 1) to almost complete incapacity (Grade 5).

Secondary outcomes

  1. Mean St. George's Respiratory Questionnaire

    Time frame: Baseline, 1 month, 2 months, and 3 months (post-intervention)

    The St. George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. It is a 50-item questionnaire with two parts, in which part one measures frequency and severity of symptoms while part two measures activities that impact breathlessness. Scores range from 0 to 100, with higher scores indicating more limitations.

  2. Mean PROMIS Pain Intensity - Short Form V10 3a

    Time frame: Baseline, 1 month, 2 months, and 3 months (post-intervention)

    PROMIS Pain Intensity instrument measures how much a person hurts. It is a 3-item instrument that evaluates how much pain the patient has felt in the past seven days. Each question about pain intensity is rated on a five-point scale from had no pain (1) to very severe (5).

  3. Mean PROMIS Fatigue - Short Form 6a

    Time frame: Baseline, 1 month, 2 months, and 3 months (post-intervention)

    PROMIS Fatigue instrument measures how much a person feels tired. It is a 6-10-item questionnaire that evaluates how tired or exhausted the patient has felt in the past seven days. Each question about fatigue is rated on a five-point scale from never (1) to always (5).

  4. Mean Short Form 36

    Time frame: Baseline, 1 month, 2 months, and 3 months (post-intervention)

    Short Form 36 (SF-36) is a well validated instrument that measures overall health status. It consists of 36 items and has eight sections.; the scores are weighted sums of the questions in each section. Scores range from 0-100. Lower scores = more disability and higher scores = less disability

  5. Mean Shared Decision Making Questionnaire

    Time frame: Baseline (immediately post-intervention)

    The Shared Decision Making (SDM) Questionnaire-9, is a patient reported, 9-item validated instrument that consists of nine statements that measure the decisional process in medical visits from both patients' and physicians' perspectives. Each statement is rated on a six-point scale from "completely disagree" to "completely agree".

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • National Institute of Nursing Research (NINR)
  • Weill Medical College of Cornell University

Registry information

Official study title

The Development and Pilot Testing of a Brief Shared Decision-Making Intervention to Improve Palliative Care Outcomes for Adults With Advanced Lung Disease

Acronym: BREATHE-ALD

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Jun 18, 2021
Registry last updated
Apr 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.